NCT01321554 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) Status COMPLETED Phase PHASE3
NCT01307761 An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules Status UNKNOWN Phase N/A
NCT01270321 Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer Status COMPLETED Phase PHASE2
NCT01265381 Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study Status TERMINATED Phase N/A
NCT01153945 Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum Status WITHDRAWN Phase N/A
NCT01141309 Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01089335 Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia Status COMPLETED Phase N/A
NCT01083550 Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01074684 Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer Status COMPLETED Phase N/A
NCT01025453 Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer Status COMPLETED Phase PHASE2
NCT00970359 Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 Status COMPLETED Phase NA
NCT00954837 Assessment of Repeat Fine Needle Aspiration (FNA) to Detect Thyroid Cancer Status WITHDRAWN Phase NA
NCT00948337 A Study With Health Educational Material on Health Promotion in Cancer Survivors Status UNKNOWN Phase PHASE2
NCT00936858 RAD001 for Patients With Radioiodine Refractory Thyroid Cancer Status COMPLETED Phase PHASE2
NCT00926978 Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH) Status TERMINATED Phase NA
NCT00896454 Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium Status COMPLETED Phase PHASE2